February 6, 2019
Transmural Cerclage™ receives FDA
IDE Early Feasibility Study (EFS) Approval for 30 patients.
April 30, 2018
Transmural Systems Announces having
Successfully Completed Enrollment of 12 subjects in the
Transcaval Closure Device IDE EFS.
November 16, 2017
Transmural Systems receives FDA
IDE Approval for Transmural Transcaval Closure Device
Early Feasibility Study (EFS) for 15 patients.